MedTrace Logo

Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis

NCT00234559 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine:

1. If vacuum assisted closure (VAC®) therapy results in altered proteomic expression of angiogenic markers compared to moist wound therapy.
2. If VAC® therapy results in increased angiogenesis compared to moist wound therapy.

Conditions

  • Wounds

Interventions

DEVICE

VAC® Therapy System

Sponsors & Collaborators

  • KCI USA, Inc

    lead INDUSTRY

Principal Investigators

  • Jeffrey A Niezgoda, M.D. · St. Luke's Medical Center of Aurora Health Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-08-31
Completion
2007-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234559 on ClinicalTrials.gov